Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does PLERIXAFOR Cause Febrile neutropenia? 69 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 69 reports of Febrile neutropenia have been filed in association with PLERIXAFOR (Plerixafor). This represents 15.4% of all adverse event reports for PLERIXAFOR.

69
Reports of Febrile neutropenia with PLERIXAFOR
15.4%
of all PLERIXAFOR reports
13
Deaths
18
Hospitalizations

How Dangerous Is Febrile neutropenia From PLERIXAFOR?

Of the 69 reports, 13 (18.8%) resulted in death, 18 (26.1%) required hospitalization, and 4 (5.8%) were considered life-threatening.

Is Febrile neutropenia Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for PLERIXAFOR. However, 69 reports have been filed with the FAERS database.

What Other Side Effects Does PLERIXAFOR Cause?

Mucosal inflammation (47) Nausea (29) Off label use (29) Dyspnoea (28) Pyrexia (27) Diarrhoea (24) Thrombocytopenia (23) Acute kidney injury (21) Acute respiratory distress syndrome (20) Escherichia infection (18)

What Other Drugs Cause Febrile neutropenia?

CYCLOPHOSPHAMIDE (11,318) DOXORUBICIN (8,844) VINCRISTINE (8,676) RITUXIMAB (6,382) CYTARABINE (6,142) METHOTREXATE (6,091) ETOPOSIDE (5,966) CARBOPLATIN (4,888) DEXAMETHASONE (4,382) PREDNISONE (3,956)

Which PLERIXAFOR Alternatives Have Lower Febrile neutropenia Risk?

PLERIXAFOR vs PNEUMOCOCCAL 13-VALENT CONJUGATE VACCINE PLERIXAFOR vs PNEUMOCOCCAL 7-VALENT CONJUGATE VACCINE PLERIXAFOR vs PNEUMOCOCCAL VACCINE POLYVALENT PLERIXAFOR vs PNEUMOCOCCAL VACCINE, POLYVALENT 23 PLERIXAFOR vs POLATUZUMAB VEDOTIN

Related Pages

PLERIXAFOR Full Profile All Febrile neutropenia Reports All Drugs Causing Febrile neutropenia PLERIXAFOR Demographics